A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.
Establishing a robust teamwork model in the practice of neuro-oncology requires continued interdisciplinary efforts. The Neuro-Oncology Scientific Club (NOSC) initiative is an interdisciplinary clinical forum promoting the comprehensive approach across involved disciplines in the management of central nervous system (CNS) malignancies. With its provincial founding panels and national steering board, NOSC has been operational in Iran since 2011. This initiative has pursued its mission through interval strategic meetings, tumor boards, case discussions as well as publishing neuro-oncology updates, case study periodicals, and newsletters. A provincial meeting of NOSC in Shiraz put together insights from international practice guidelines, emerging evidence, and expert opinions to draw a position statement on high-grade glioma management in adults. The present report summarizes key highlights from the above clinical forum.
Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mansour
M
Ansari
Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ahmad
A
Mosalaei
Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Niloufar
N
Ahmadloo
Department of Radiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza
A
Rasekhi
Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Bita
B
Geramizadeh
Department of Neurosurgery, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Ali
A
Razmkon
Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Kazem
K
Anvari
Behestan Medical Scientific Committee, Behestan Group, Tehran, Iran.
Mohammad
M
Afarid
Behestan Medical Scientific Committee, Behestan Group, Tehran, Iran; Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Ali
A
Dadras
Behestan Medical Scientific Committee, Behestan Group, Tehran, Iran.
Leila
L
Nafarieh
Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad
M
Mohammadianpanah
Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Hamid
H
Nasrolahi
Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Hasan
SH
Hamedi
Department of Radiation Oncology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Shapour
S
Omidvari
Behestan Medical Scientific Committee, Behestan Group, Tehran, Iran; Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran; Neuroscience Laboratory (Brain, Cognition and Behavior), Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran; Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad
M
Nami
D000328:Adult; D001932:Brain Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy*; D003131:Combined Modality Therapy; D019091:Critical Pathways; D005910:Glioma / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D007492:Iran; D008279:Magnetic Resonance Imaging; D008495:Medical Oncology / Q000379:methods / Q000458:organization & administration; D059906:Neuroimaging; D010348:Patient Care Team / Q000458:organization & administration
Shiraz; high-grade glioma; interdisciplinary; neuro-oncology; position statement